Searchable abstracts of presentations at key conferences in endocrinology

ea0026p61 | Endocrine tumours and neoplasia | ECE2011

Liposome based strategies for the treatment of adrenocortical carcinoma

Hantel C , Lewrick F , Reincke M , Suss R , Beuschlein F

Medical treatment of adrenocortical carcinoma (ACC) is limited to common cytotoxic agents, which are usually given in combination with mitotane. Recently we have developed a novel therapeutic approach by coupling a monoclonal IGF1 receptor blocking antibody (1H7) to sterically stabilized liposomal doxorubicin (SSLD). 1H7 coupled liposomes showed in vitro high and significant cellular association and furthermore internalization in various human tumor cell lines as well a...

ea0026p88 | Endocrine tumours and neoplasia | ECE2011

cAMP induces PATZ1 and estrogen receptor β nuclear re-localization in the human seminoma TCam-2 cell line

Boscia F , Esposito F , Kitazawa S , Looijenga L , Chieffi P

Estrogen exposure has been linked to a risk for the development of testicular germ cell cancers. The effects of estrogen are now known to be mediated by estrogen receptor α (ERα) and ERβ subtypes, but only ERβ has been found in human germ cells of normal testis. However, its expression was markedly diminished in seminomas, embryonal cell carcinomas, and in mixed germ cell tumours but remains high in teratomas. PATZ1 is a recently discovered zinc finger prot...

ea0003p225 | Reproduction | BES2002

Oral clatharate-DHEA as a potential form of androgen replacement in hypogonadal men. A phase 2, open label, placebo controlled, parallel group pharmacokinetic study

Oxynos C , Phillips J , Laing I , Saad F , Wu F

BACKGROUND: DHEA and DHEAS, can be converted into Androstenedione, T and DHT as well as oestrogens by peripheral tissues. In normal men the conversion rate of IV-infused radiolabelled DHEAS to T is only 0.7%. In hypogonadal men, this conversion rate may be increased. We hypothesise that a pharmacological dose of orally administered DHEA may be able to raise plasma T into the normal range in hypogonadal men. METHODS: Local Ethical Committee Approval was obtained. Two groups (n=...

ea0002p10 | Clinical case reports | SFE2001

GRAVES THYROTOXICOSIS FOLLOWING HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY INDUCED IMMUNE RECONSTITUTION

Hannan F , Chen F , Scullard G , Robinson S

We report a 36 year old woman of African origin with a background of HIV and previous AIDS defining pulmonary tuberculosis. The patient has been well on highly active anti-retroviral therapy (HAART) since May 2000. She presented in March 2001 with a four weeks history of fatigue, weight loss, palpitations, polyuria and weakness. Her mother had type 2 diabetes. There is no family history of thyroid disease. Examination showed a thyrotoxic state, a smooth diffuse goitre and prox...

ea0083to2 | Thyroid | EYES2022

Subacute thyroiditis (SAT) during the COVID-19 pandemic: preliminary data from the “ESE Covid Grant 2021” project

E. Zanni , S. Loiacono , R. Sueri , C Cecchetti , E Crivicich , F Di Marco , I. Muller , L Tucci , S. De Vincentis , L. Monzani M. , M. Simoni , D. Santi , G. Brigante

Background: A possible association between severe acute respiratory syndrome coronavirus (SARS-CoV)-2 pandemic and subacute thyroiditis (SAT) has been reported.Objectives: To evaluate SAT clinical characteristics, correlating them to virus exposure and/or vaccine and to evaluate thyroid function according to the length of time after symptoms onset.Methods: We performed a prospective, observational, multi-centre study, considering t...

ea0035s9.3 | EYES Session - Cold metabolic inflammation in obesity: ignored complication and treatment target? | ECE2014

The emerging landscape for nanomedicine in atherosclerosis

van der Valk F M

Major clinical events such as myocardial infarction and stroke are caused by atherosclerosis, a lipid-driven chronic inflammatory disease affecting the arterial wall. In recognition of the inflammatory drive in cardiovascular disease (CVD), a major interest has risen to complement current standards for high-risk patients by therapeutically targeting the inflammatory process. Prior to clinical application, therapeutic candidates are required to have a robust anti-inflammatory e...

ea0029s62.2 | Early Development and Treatment of PCOS | ICEECE2012

Early development and pubertal prevention of polycystic ovary syndrome

de Zegher F. , Ibanez L.

PCOS (defined by NIH, Rotterdam or AES criteria) is traditionally viewed as an ovarian disorder that appears in adolescence and may lead to metabolic complications in adulthood. Emerging evidence, however, indicates that PCOS is primarily a disorder of adipose-tissue hyperexpansion that may originate in early life, develop across childhood and puberty, and advance into end-stage disease (including ovulatory dysfunction and ovarian androgen excess) by adolescence. Prepubertal m...

ea0029oc14.3 | Male Reproduction | ICEECE2012

Comparison of serum testosterone and estradiol levels in 3174 European men as measured by a platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men

Huhtaniemi I. , Tajar A. , Wu F.

Testosterone (T) and estradiol (E2) are the two most important sex steroids in men and women, respectively, and their accurate determination in serum is of crucial importance in assessing gonadal function both in clinical management and research. The limitations of serum T and E2 measurements using non-extraction platform immunoassays (IA) are widely recognized. Switching to more specific mass spectrometry (MS)-based methods has been advocated but directly comparative data on ...

ea0029p124 | Adrenal medulla | ICEECE2012

Incidentally discovered pheochromocytoma (PH)

Kesri N. , Boudiba A. , Chentli F.

The main concern of endocrinologist exploring an adrenal incidentaloma (AI) is the identification of malignant and/or secretant AI leading to rapid cure by removal of the tumor. PH remains one of the most difficult lesions to diagnose. In this study we analyze PH clinic, morphologic and secretory profile. Among a series of 91 AI recruited between 1987 and 2007 having benefited from an adrenal exploration, 56 have been removed and 18/56 were diagnosed as tumors of medullar orig...

ea0029p315 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Effects of long-term treatment of hypogonadal men with testosterone undecanoate on blood pressure, fasting glucose, HbA1c and C-reactive protein

Saad F. , Haider A. , Gooren L.

Introduction: Hypogonadism is associated with metabolic syndrome and all its individual components. This study analysed effects of normalization of serum testosterone in mainly elderly, hypogonadal men.Methods: Prospective registry study of 252 men (mean age 60.6±8.0 years), with testosterone levels between ≤3.5 ng/ml. They received parenteral testosterone undecanoate 1000 mg at day 1, week 6 and every 12 weeks thereafter for up to 66 months.<...